NP Life Sciences Health Industry Group Inc. financial data

Location
4125 Blackhawk Plaza Circle, Suite 166, Danville, CA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
GJ Culture Group US, Inc. (to 9/29/2022)
Latest financial report
10-K - Q4 2023 - Apr 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 267 % +266%
Return On Equity 148 %
Return On Assets -2.56 % +93.7%
Operating Margin -0.42 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43M shares 0%
Common Stock, Shares, Outstanding 43M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 4.3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 43M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 43M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 165K USD
General and Administrative Expense 165K USD +36.8%
Operating Income (Loss) -690 USD +96.3%
Nonoperating Income (Expense) -225 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -37.4K USD -588%
Net Income (Loss) Attributable to Parent -2.94K USD +84.4%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.6K USD -42.1%
Assets 76.9K USD -39.8%
Accounts Payable, Current 6.13K USD 0%
Accrued Liabilities, Current 25.1K USD +904%
Contract with Customer, Liability, Current 10K USD
Liabilities, Current 38.1K USD -64.9%
Liabilities 60.5K USD -44.2%
Retained Earnings (Accumulated Deficit) -348K USD -0.85%
Stockholders' Equity Attributable to Parent 31.7K USD +1068%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 16.4K USD -15.2%
Liabilities and Equity 76.9K USD -39.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.2K USD
Common Stock, Shares Authorized 320M shares 0%
Common Stock, Shares, Issued 43M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 18.2K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 30M shares 0%
Additional Paid in Capital 360K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%